81 results match your criteria: "Michallon University Hospital[Affiliation]"

Background: The over-the-scope clip proctology system is rather new and information regarding its use for the closure of anorectal fistulas is scarce. No study has been designed to focus exclusively on its application in the treatment of rectovaginal fistulas. The aim of the study was to evaluate the feasibility, safety, and effectiveness of the clip for rectovaginal fistula repair.

View Article and Find Full Text PDF

Background: Although outcomes of critically ill patients with haematological malignancies (HMs) have been fully investigated in terms of organ failure and mortality, data are scarce on health-related quality of life (HRQOL) in this population. We aim to assess post-intensive care unit (ICU) burden and HRQOL of critically ill patients with HMs and to identify risk factors for quality-of-life (QOL) impairment.

Results: In total, 1011 patients with HMs who required ICU admission in 17 ICUs in France and Belgium were included in the study; 278 and 117 patients were evaluated for QOL at 3 months and 1 year, respectively, after ICU discharge.

View Article and Find Full Text PDF

Ambulatory colectomy: fast-track management pushed to its limits?

Tech Coloproctol

October 2018

Colorectal Unit, Department of Surgery, Michallon University Hospital, Grenoble, CS 10217, 38043, Grenoble Cedex, France.

View Article and Find Full Text PDF

In patients with hematologic malignancies, respiratory status may deteriorate during neutropenia recovery. This multicenter, observational study aims to evaluate granulocyte colony-stimulating factor (G-CSF) impact on respiratory status in critically ill neutropenic patients. Among 1011 critically ill patients with hematologic malignancies, 288 were neutropenic and included in this study.

View Article and Find Full Text PDF

Background: Surgical treatment for low rectal cancer septic complications often requires an ileostomy for fecal diversion. Delayed coloanal anastomosis (CAA) has been performed for several years to reduce septic complications and to avoid ileostomy. The aim of this study was to report the technical, functional and oncological results of delayed CAA in patients operated on for low rectal cancer focusing on pelvic septic complications.

View Article and Find Full Text PDF

The members of the OUTCOMEREA Study Group were provided in such a way that they could not be indexed as collaborators on PubMed. The publisher apologizes for this error and is pleased to list the members of the group here.

View Article and Find Full Text PDF

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

N Engl J Med

June 2018

From the Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis, Hepatology and Gastroenterology Department, Saint-Antoine University Hospital, Assistance Publique-Hôpitaux de Paris (APHP) (C.C., O.C., S.L., F.G., R.P.), INSERM Unité Mixte de Recherche (UMR) S938 (C.C., O.C., S.L., R.P.) and the Biochemistry Laboratory (L.H., D.R.), Saint-Antoine University Hospital, APHP, INSERM Unité 1157/UMR 7203, Sorbonne University, the Biochemistry Laboratory, Tenon University Hospital, APHP (G.L.), and the Immunology Laboratory, INSERM UMR S996, Bichat University Hospital, APHP (L.C., S.C.-M.), Paris-Sud University, the Department of Clinical Pharmacology and Clinical Research Platform of the East of Paris, APHP (A.R., F.-H.A., T.S.), and Sorbonne University (T.S.), Paris, the Hepatology and Gastroenterology Department, Rouen University Hospital, Rouen (O.G.), the Hepatology and Gastroenterology Department, Pontchaillou University Hospital, Rennes (A.L.G.), the Hepatology and Gastroenterology Department, University Hospitals of Strasbourg, Institute of Viral and Liver Diseases, INSERM Unité 1110, Laboratory of Excellence HepSYS, University of Strasbourg, Strasbourg (F.H.), the Hepatology and Gastroenterology Department, Claude Huriez University Hospital, Lille (P.M.), the Hepatology and Gastroenterology Department, Orleans Hospital, Orleans (P.P.), the Hepatology and Gastroenterology Department, Dijon Bourgogne University Hospital, Dijon (A.M.), the Hepatology and Gastroenterology Department, University Hospital of Poitiers, Poitiers (C.S.), the Hepatology and Gastroenterology Department, Estaing University Hospital, Clermont-Ferrand (A.A.), the Hepatology and Gastroenterology Department, University Hospital of Limoges, Limoges (M.D.-G.), the Hepatology and Gastroenterology Department, Saint-Eloi University Hospital, Montpellier (D.L.), the Hepatology Department, Beaujon University Hospital, Clichy (O.R.), the Hepatology and Gastroenterology Department, Brabois University Hospital, Nancy (J.-P.B.), the Hepatology and Gastroenterology Department, University Hospital of Angers, Hemodynamics, Interaction, Fibrosis, and Tumor Invasiveness in Hepatic and Digestive Organs Laboratory, Unité Propre de Recherche de l'Enseignement Supérieur 3859, Structures Fédératives de Recherche 4208, Bretagne Loire University, Angers (J.B.), the Hepatology and Gastroenterology Department, Haut-Lévêque University Hospital, Pessac (V.L.), the Hepatology and Gastroenterology Department, Robert Debré University Hospital, Reims (A.H.-B.), the Hepatology and Gastroenterology Department, University Hospital of Amiens, Amiens (E.N.-K.), the Hepatology and Gastroenterology Department, Croix-Rousse University Hospital, Lyon (F.Z.), the Hepatology and Gastroenterology Department, University Hospital of Caen, Caen (I.O.-H.), the Hepatology and Gastroenterology Department, Michallon University Hospital, Grenoble (J.-P.Z.), and the Hepatology and Gastroenterology Department, Jean Verdier University Hospital, Bondy (G.N.) - all in France.

Background: Patients with primary biliary cholangitis who have an inadequate response to therapy with ursodeoxycholic acid are at high risk for disease progression. Fibrates, which are agonists of peroxisome proliferator-activated receptors, in combination with ursodeoxycholic acid, have shown potential benefit in patients with this condition.

Methods: In this 24-month, double-blind, placebo-controlled, phase 3 trial, we randomly assigned 100 patients who had had an inadequate response to ursodeoxycholic acid according to the Paris 2 criteria to receive bezafibrate at a daily dose of 400 mg (50 patients), or placebo (50 patients), in addition to continued treatment with ursodeoxycholic acid.

View Article and Find Full Text PDF

Purpose: To investigate the clinical significance of infection-related ventilator-associated complications (IVAC) and their impact on carbapenem consumption in mechanically ventilated (MV) patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLE).

Methods: Inception cohort study from the French prospective multicenter OUTCOMEREA database (17 ICUs, 1997-2015) including all ESBLE carriers (systematic rectal swabbing at admission then weekly and/or urinary or superficial surgical site colonisation) with MV duration > 48 h and ≥ 1 episode of IVAC after carriage documentation. All ICU-acquired infections were microbiologically documented.

View Article and Find Full Text PDF

Background: Cardiac resynchronization therapy (CRT) is an effective treatment of heart failure (HF), but is limited by a substantial proportion of nonresponders. We hypothesized that adding a second left ventricular (LV) lead to deliver a triple-site CRT (V CRT) may improve clinical status of CRT nonresponders.

Objective: We assessed the feasibility and safety of adding a second LV lead to CRT nonresponders and its clinical impact.

View Article and Find Full Text PDF

The ICU-Diary study: prospective, multicenter comparative study of the impact of an ICU diary on the wellbeing of patients and families in French ICUs.

Trials

November 2017

Infection, Antimicrobials, Modelling, Evolution (IAME), UMR 1137, INSERM and Paris Diderot University, Department of Biostatistics - HUPNVS - AP-HP, UFR de Médecine - Bichat University Hospital, Paris, France.

Background: Post-intensive care syndrome includes the multiple consequences of an intensive care unit (ICU) stay for patients and families. It has become a new challenge for intensivists. Prevention programs have been disappointing, except for ICU diaries, which report the patient's story in the ICU.

View Article and Find Full Text PDF

Hedrocele Associated With Full-Thickness Rectal Prolapse: A Very Rare Condition Treated by Ambulatory Laparoscopic Anterior Rectopexy.

Dis Colon Rectum

September 2017

1 Colorectal Unit, Department of Surgery, Michallon University Hospital, Grenoble, France 2 University Grenoble Alps, UMR 5525, CNRS, TIMC-IMAG, Grenoble, France 3 Ambulatory Unit, Department of Surgery, Michallon University Hospital, Grenoble, France.

View Article and Find Full Text PDF

Proctologic surgery done by residents: Who is the surgeon in real life?

J Visc Surg

December 2016

Colorectal Unit, Department of Surgery, Michallon University Hospital, 38000 Grenoble, France; University Grenoble Alps, UMR 5525, CNRS, TIMC-IMAG, 38000 Grenoble, France.

View Article and Find Full Text PDF

Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.

J Infect

February 2017

INSERM, IAME, UMR 1137, Team DesCID, F-75018 Paris, France; Medical Intensive Care Unit, Assistance Publique des Hôpitaux de Paris (AP-HP), Bichat University Hospital, Paris, France.

Objectives: ICU-acquired bloodstream infection (ICUBSI) in Intensive Care unit (ICU) is still associated with a high mortality rate. The increase of antimicrobial drug resistance makes its treatment increasingly challenging.

Methods: We analyzed 571 ICU-BSI occurring amongst 10,734 patients who were prospectively included in the Outcomerea Database and who stayed at least 4 days in ICU.

View Article and Find Full Text PDF

Importance: Although frequently used in treating intensive care unit (ICU) patients with sepsis, empirical antifungal therapy, initiated for suspected fungal infection, has not been shown to improve outcome.

Objective: To determine whether empirical micafungin reduces invasive fungal infection (IFI)-free survival at day 28.

Design, Setting, And Participants: Multicenter double-blind placebo-controlled study of 260 nonneutropenic, nontransplanted, critically ill patients with ICU-acquired sepsis, multiple Candida colonization, multiple organ failure, exposed to broad-spectrum antibacterial agents, and enrolled between July 2012 and February 2015 in 19 French ICUs.

View Article and Find Full Text PDF

Cost-effectiveness of New Surgical Treatments for Hemorrhoidal Disease: A Multicentre Randomized Controlled Trial Comparing Transanal Doppler-guided Hemorrhoidal Artery Ligation With Mucopexy and Circular Stapled Hemorrhoidopexy.

Ann Surg

November 2016

*Colorectal Unit, Institut des Maladies de l'Appareil Digestif (IMAD), University Hospital of Nantes, Nantes, France †Colorectal Unit, Department of Surgery, Michallon University Hospital, Grenoble, France ‡Colorectal Unit, Department of Surgery, University Hospital of Lille, Lille, France §Department of Proctology, University Hospital of Rennes, Rennes, France ¶Department of Digestive Surgery, Poissy Hospital, Saint-Germain en Laye, France ||Department of Digestive Surgery, Vichy Hospital, Vichy, France **Department of Surgery, University Hospital of Angers, Angers, France ††Unit of Methodology and Biostatistics, University Hospital of Nantes, Nantes, France ‡‡Health economics and health policy research unit, AP-HP Paris, France.

Objective: To compare Doppler-guided hemorrhoidal artery ligation (DGHAL) with circular stapled hemorrhoidopexy (SH) in the treatment of grade II/III hemorrhoidal disease (HD).

Background: DGHAL is a treatment option for symptomatic HD; existing studies report limited risk and satisfactory outcomes. DGHAL has never before been compared with SH in a large-scale multi-institutional randomized clinical trial.

View Article and Find Full Text PDF

To Drain or Not to Drain Infraperitoneal Anastomosis After Rectal Excision for Cancer: The GRECCAR 5 Randomized Trial.

Ann Surg

March 2017

*Colorectal Unit, Haut Lévêque Hospital, CHU Bordeaux, France †University of Bordeaux, Bordeaux, France ‡Surgical Oncology Department, Montpellier Cancer Institute (ICM), Val d'Aurelle, Montpellier, France §Colorectal Unit, Department of Surgery, Michallon University Hospital, Grenoble, France ¶University Grenoble Alpes, Grenoble, France ||Department of Colorectal Surgery, Beaujon Hospital (AP-HP), Paris VII University, Clichy, France **Department of Surgery, Pontchaillou University Hospital, Rennes, France ††Department of Digestive Surgery, Hospital Center Lyon-Sud, University of Lyon, Lyon, France ‡‡Department of Surgery, Hotel Dieu University Hospital, Nantes, France §§Department of Surgery, Purpan University Hospital, Toulouse, France ¶¶Department of Digestive and Oncological Surgery, Amiens Picardie University Hospital, Amiens, France ||||Inserm Unit, Picardie Jules-Verne University, Amiens, France ***Department of Digestive Surgery, Saint-Joseph Hospital, Paris, France †††Department of Surgery, Bicêtre University Hospital (AP-HP), Le Kremlin-Bicêtre cedex, France ‡‡‡Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, UniversityLille, Lille, France §§§Department of General and Digestive Surgery, University of Aix Marseille, Marseille, France ¶¶¶Department of Digestive and Oncological Surgery, Paoli-Calmettes Institute, Marseille, France ||||||Department of Digestive Surgery, Beauvais Hospital, Beauvais, France ****Department of General and Digestive Surgery, Strasbourg University Hospital, Strasbourg, France ††††Department of Digestive Surgery, University Hospital of Poitiers, Poitiers, France ‡‡‡‡Medical Information Department, USMR, CHU de Bordeaux-Public health pole, Bordeaux, France §§§§INSERM, ISPED, INSERM Center U897-Epidemiology-Biostatistic, Bordeaux, France ¶¶¶¶ISPED, INSERM U897 Center-Epidemiology-Biostatistic, University Bordeaux, Bordeaux, France.

Objective: To assess the effect of pelvic drainage after rectal surgery for cancer.

Background: Pelvic sepsis is one of the major complications after rectal excision for rectal cancer. Although many studies have confirmed infectiveness of drainage after colectomy, there is still a controversy after rectal surgery.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify factors influencing how micafungin is processed in the body and to determine if the standard 100 mg dose is effective for ICU patients with sepsis and on mechanical ventilation.
  • The research included 100 patients and analyzed 436 drug concentration measurements using advanced software to evaluate its pharmacokinetics.
  • Results showed variability in drug clearance and distribution related to patient conditions, suggesting that higher doses may be necessary for certain infections, especially those caused by Candida parapsilosis and when drug resistance is present.*
View Article and Find Full Text PDF